Skip to main content
. 2020 Aug 14;26:e925107-1–e925107-17. doi: 10.12659/MSM.925107

Supplementary Table 1.

Sociodemographic and clinical characteristics of study patients after propensity score matching.

Characteristic Overall (n=202) Chemotherapy (n=101) No chemotherapy (n=101) P value
Age (year) <60 97 (48.0) 49 (48.5) 48 (47.5) 1
≥60 105 (52.0) 52 (51.5) 53 (52.5)
Gender Male 91 (45.0) 46 (45.5) 45 (44.6) 1
Female 111 (55.0) 55 (54.5) 56 (55.4)
Race White 163 (80.7) 81 (80.2) 82 (81.2) 0.93
Black 25 (12.4) 12 (11.9) 13 (12.9)
Other 14 (6.9) 8 (7.9) 6 (5.9)
Insurance type Insured 66 (32.7) 32 (31.7) 34 (33.7) 0.761
Any medicaid 13 (6.4) 8 (7.9) 5 (5.0)
Unknown 123 (60.9) 61 (60.4) 62 (61.4)
Marital status Single 35 (17.3) 18 (17.8) 17 (16.8) 0.898
Widowed/divorced 47 (23.3) 25 (24.8) 22 (21.8)
Married 113 (55.9) 54 (53.5) 59 (58.4)
Unknown 7 (3.5) 4 (4.0) 3 (3.0)
Year of diagnosis 1976 to 1985 16 (7.9) 7 (6.9) 9 (8.9) 0.796
1986 to 1995 28 (13.9) 12 (11.9) 16 (15.8)
1996 to 2005 63 (31.2) 33 (32.7) 30 (29.7)
2006 to 2016 95 (47.0) 49 (48.5) 46 (45.5)
Primary site Extremity 84 (41.6) 41 (40.6) 43 (42.6) 0.981
Trunk 53 (26.2) 26 (25.7) 27 (26.7)
Visceral 37 (18.3) 19 (18.8) 18 (17.8)
Other 28 (13.9) 15 (14.9) 13 (12.9)
Grade Grade I/II 12 (5.9) 6 (5.9) 6 (5.9) 0.816
Grade III/IV 134 (66.3) 65 (64.4) 69 (68.3)
Unknown 56 (27.7) 30 (29.7) 26 (25.7)
Stage Localized 91 (45) 44 (43.6) 47 (46.5) 0.972
Regional 68 (33.7) 35 (34.7) 33 (32.7)
Distant 34 (16.8) 17 (16.8) 17 (16.8)
Unstaged 9 (4.5) 5 (5.0) 4 (4.0)
Tumor size (mm) <73 99 (49.0) 52 (51.5) 47 (46.5) 0.574
≥73 103 (51.0) 49 (48.5) 54 (53.5)
Radiation Yes 54 (26.7) 25 (24.8) 29 (28.7) 0.634
No 148 (73.3) 76 (75.2) 72 (71.3)
Surgery Yes 175 (86.6) 86 (85.1) 89 (88.1) 0.680
No 27 (13.4) 15 (14.9) 12 (11.9)

mm – millimeter.